cognitive cybersecurity intelligence

News and Analysis

Search

Vertex Bucks Bear Market with Boston Expansion, CF Growth

Another factor in Vertex’s stock rising this week relates to its collaborations with Moderna, including partnerships to discover and develop mRNA therapies for cystic fibrosis (CF), as well as to discover and develop inhalable lipid nanoparticles (LNPs) to deliver those therapies….

Source: www.genengnews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts